Request Sample Inquiry
Vitamin K2 Market

Vitamin K2 Market

Vitamin K2 Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

182

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1222

Segments Covered
  • By Product By Product MK-7, MK-4, Others
  • By Source By Source Natural, Synthetic
  • By Form By Form Oil, Powder, Others
  • By Application By Application Nutraceutical, Food, Pharmaceuticals
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 564.75 Million
Revenue 2030Revenue 2030: USD 3475.41 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 25.50%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Europe
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Research Methodology: Vitamin K2 Market by Product by Source by Form by Application by Region - Global Market Assessment, 2021 - 2028

Secondary Research

Primary Research:

Data Triangulation and Market Size Estimations

FAQ
Frequently Asked Question
  • The global Vitamin K2 valued at USD 564.75 Million in 2022 and is expected to reach USD 3475.41 Million in 2030 growing at a CAGR of 25.50%.

  • The prominent players in the market are Kappa Bioscience, NattoPharma, GNOSIS S.p.A., Viridis BioPharma, Seebio Biotech, DSM, DuPont, Geneferm Biotechnology Co. Ltd., International Flavors & Fragrances, Inc., and KYOWA HAKKO BIO CO., LTD..

  • The market is project to grow at a CAGR of 25.50% between 2023 and 2030.

  • The driving factors of the Vitamin K2 include

    • Increasing Patient Pool Suffering From Vitamin Deficiency

  • North America was the leading regional segment of the Vitamin K2 in 2022.